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Background: Mitochondria exhibit a dynamic morphology in cells and their biogenesis and function are integrated
with the nuclear cell cycle. In mitotic cells, the filamentous network structure of mitochondria takes on a
fragmented form. To date, however, whether mitochondrial fusion activity is regulated in mitosis has yet to be
elucidated.
Findings: Here, we report that mitochondria were found to be fragmented in G2 phase prior to mitotic entry.
Mitofusin 1 (Mfn1), a mitochondrial fusion protein, interacted with cyclin B1, and their interactions became stronger
in G2/M phase. In addition, MARCH5, a mitochondrial E3 ubiquitin ligase, reduced Mfn1 levels and the
MARCH5-mediated Mfn1 ubiquitylation were enhanced in G2/M phase.
Conclusions: Mfn1 is degraded through the MARCH5-mediated ubiquitylation in G2/M phase and the cell
cycle-dependent degradation of Mfn1 could be facilitated by interaction with cyclin B1/Cdk1 complexes.
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Mitochondria are multifunctional organelles that play es-
sential roles in many cellular functions, including respir-
ation, ATP production, and calcium buffering [1,2]. In
most cell types, mitochondria form a tubular network
structure whose morphology changes dynamically through
a controlled balance of fusion and fission events. Mitofu-
sins (Mfn1/2) and Opa1 (optic atrophy 1) are essential for
the fusion of mitochondrial outer and inner membranes,
respectively. Drp1 (dynamin related protein 1) has pivotal
roles in fission events through association with Fis1 (fis-
sion 1) or Mff [3,4]. An imbalance in mitochondrial dy-
namics affects cellular physiology. For example,
abnormally elongated mitochondria, caused by depletion
of Fis1 or MARCH5, induce cellular senescence [5,6].
Moreover, extensive mitochondrial fragmentation is
observed in apoptotic cells, whereas cells with elongated
mitochondria are more resistant to apoptotic stimuli [7,8].* Correspondence: hscho@ajou.ac.kr
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reproduction in any medium, provided the orMitochondrial biogenesis and function are integrated
with the nuclear cell cycle. Diminished production of ATP
caused by mutations in the mitochondrial protein, tenured
(tend), which encodes a cytochrome oxidase subunit Va,
causes G1/S cell-cycle arrest during larval growth in Dros-
ophila [9]. Mitochondrial function is also affected by p53
[10]. Additionally, mitochondria are known to show dy-
namic morphology during cell-cycle stages [11-13]. Cyclin
D1, a G1/S-phase controlling protein, represses mitochon-
drial function and size [10,14]. During G1/S phase, mito-
chondria form a hyper-fused giant network that regulates
cyclin E accumulation [15]; this thin, filamentous struc-
ture radiates from the perinuclear region to the periphery
and its formation increases mitochondrial mass [11]. Sub-
sequent cell-cycle events during G2/M phase act as a
checkpoint against DNA damage and ensure entry into
mitosis where chromosomes are partitioned equally to
two daughter cells. Other organelles and cellular compo-
nents must also be segregated between the two daughter
cells during mitosis. It is reported that mitochondrial frag-
mentation occurs early in mitosis (prophase) and requires
phosphorylation of Drp1 by Cdk1/cyclin B1 [11,16]. It is
also shown that mitochondria fully develop their mito-
chondrial membrane potential at G2/M [17]. Despite the
connection between mitochondrial function/dynamicsl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the underlying mechanism. This is especially true with re-
spect to the function of mitochondrial fusion proteins in
the mitotic fragmentation of mitochondria.
Here, we attempted to address whether mitochondrial
fusion activity is also regulated during G2/M phase. We
recognized that the mitochondrial fusion protein, Mfn1,
contains a putative target sequence for phosphorylation
by the cyclin B1/Cdk1 complex and in fact found thatFigure 1 Formation of fragmented mitochondria at G2 phase. (A) Cells w
method. Images were analyzed by confocal microcopy. Scale bars = 10 μmMfn1 interacted with cyclin B1. In G2/M phase, ubiquity-
lation of Mfn1 by MARCH5 is increased and Mfn1 levels
are reduced through proteasome-mediated degradation.
Thus, cell cycle-dependent degradation of Mfn1 could be
facilitated by interaction with cyclin B1/Cdk1 complexes.
Mfn1 interacts with Cdk1/cyclin B1
To investigate mitochondrial morphological changes
during cell-cycle progression in detail, we synchronizedere synchronized and released at the indicated phase using the DTB
.
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(DTB) method, after which mitochondria were stained
with MitoTracker Red and analyzed by confocal micros-
copy. CENP-F, which predominantly localizes to the nu-
clear matrix at G2 phase and moves to the nuclearFigure 2 Mfn 1 interacts with Cdk1/cyclin B1. (A) G2/M-phase cells were
immunoprecipitated with an anti-cyclin B1 antibody, followed by immunob
obtained by taxol treatment for 12 h. The association to cyclin B1 was anal
an anti-Mfn1 antibody. (C) Cells were treated with MG132 with or without
antibody, followed by immunoblotting with the indicated antibodies. Arrow
synchronized at G1/S, G2 or mitotic phase by treatment with thymidine, ro
for 2 h at R8 after DTB release, respectively. Mitochondrial morphology was
confocal microcopy. Scale bars = 10 μm.membrane and kinetochores during late G2 phase and
mitosis, respectively [18], was used as a cell-cycle mar-
ker. In G1/S-arrested cells, mitochondria formed an
interconnected network structure (Figure 1, left). How-
ever, G2-phase cells showed fragmented mitochondriaobtained by harvesting cells after nocodazole treatment. Lysates were
lotting with the indicated antibodies. (B) G2/M-phase cells were
yzed by immunoblotting, after lysates were immunoprecipitated with
nocodazole. Lysates were immunoprecipitated with an anti-cyclin B1
s (NS, upper two bands) indicate non-specific binding. (D) Cells were
scovitine (Ros, 100 μM) for 5 h at 7 h after DTB release or nocodazole
observed by staining with MitoTracker Red. Images were analyzed by
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go fragmentation before mitotic entry. In mitotic cells,
mitochondria fragmented remained small and punctate
form (Figure 1, right). These changes in mitochondrial
morphological features during the cell cycle are mostly
consistent with previous studies [11,12,17,19]; however,
the mechanism underlying these mitochondrial dynam-
ics have been partly understood.
It is known that the mitochondrial fission factor Drp1 is
phosphorylated by Cdk1/cyclin B1 and phosphorylated-
Drp1 induces mitochondrial fragmentation, which is
important in G2/M transition [16]. However, despite a
general recognition that mitochondrial morphology is
controlled through a balancing of fusion and fission, the
relationship between mitotic fragmentation and mito-
chondrial fusion has received little research attention. We
thus attempted to identify the mechanism regulating the
fusion event at the G2/M transition. During this transition,
multiple possible post-translational modifications of fu-
sion factors might take place. Accordingly, we hypothe-
sized that mitochondrial fusion factors are regulated
during cell-cycle progression. We recognized that Mfn1
contains one potential recognition site (at serine 6) of cyc-
lin B1/Cdk1, a serine/threonine kinase that recognizes the
consensus motif [S/T]PX[K/R] [20]. Therefore, we exam-
ined whether Mfn1 interacts with cyclin B1 using co-
immunoprecipitation assay. To collect cells in G2/M
phase, cells were collected after treatment with nocoda-
zole or taxol for 12 h. Co-immunoprecipitates using anti-
cyclin B1 antibody revealed that Mfn1 interacted with
cyclin B1 and the levels of cyclin B increase and there is
more of it bound to Mfn1 in G2/M phase than those in
asynchnously (Asy) growing cells (Figure 2A, C). Recipro-
cal co-immunoprecipitation with anti-Mfn1 antibody also
showed the interaction of Mfn1 to cyclinB/Cdk1 complex
(Figure 2B). Since Mfn1 is localized to the mitochondrial
outer membrane, we next examined whether cyclin B1 is
also localized to mitochondria. Immunofluorescence stain-
ing showed an accumulation of cyclin B1 in G2/M phase
(Figure 2D, left). Co-immunostaining with mitochondria
displayed the speckles of cyclin B1 (green) overlaid with
mitochondria (Figure 2D, right) in G2/M phase. Thus, the
data suggest that Mfn1 may serve as a substrate of
the Cdk1/cyclin B1 complex in G2/M phase. In addition,
the interaction between Mfn1 and Cdk1/cyclin B1 was
increased in the presence of MG132, a proteasome inhibi-
tor (Figure 2C), also suggesting that the binding of Mfn1
to the cyclin B1/Cdk1 complex stimulate the degradation
of Mfn1 through a proteasome-dependent pathway.
Mfn1 levels are regulated by MARCH5-mediated
ubiquitylation in G2/M phase
MARCH5 is a mitochondrial E3-ubiquitin ligase that
localizes to the mitochondrial outer-membrane andubiquitylates proteins that control mitochondrial dy-
namics [6,21-23]. As we reported recently, Mfn1 is a
novel substrate of MARCH5. Though Mfn1 shows high
similarity of amino acid sequence with Mfn2, the expres-
sion levels of Mfn2 were not affected by MARCH5 [6].
Thus, we next investigated whether Mfn1 is regulated by
MARCH5 in a cell cycle-dependent manner. We ob-
served that Mfn1 levels were decreased in HeLa cells
overexpressing MARCH5 (Figure 3A). It is of note that
Mfn1 levels were even more reduced in cells treated
with nocodazole (Figure 3A, compare lanes 3 and 4), in-
dicating that the MARCH5-mediated reduction of Mfn1
levels is accelerated in G2/M phase. Moreover, the
decreased level of Mfn1 was recovered by blocking the
proteasome-mediated degradation with MG132
(Figure 3A, Lane 6). Taken together, our results suggest
that degradation of Mfn1 at the G2/M phase is regulated
by MARCH5.
Next, to verify that MARCH5 ubiquitylates Mfn1 in
G2/M phase, we performed ubiquitylation assays in
HeLa cells co-transfected with GFP-Mfn1 and Myc-
MARCH5, and synchronized at G2/M by treatment with
nocodazole. Interestingly, G2/M-phase cells expressing
wild-type MARCH5 (Myc-MARCH5 WT) showed
higher levels of Mfn1 ubiquitylation, indicating that
Mfn1 is extensively ubiquitylated at G2/M by MARCH5
(Figure 3B). Next, we clarified whether the ubiquitylation
of Mfn1 is dependent on the RING domain of MARCH5
[6]. After cells were co-transfected with HA-tagged ubi-
quitin and Myc-MARCH5 WT or Myc-MARCH5H43W,
containing an inactivating mutation in the RING domain,
G2/M-phase cells were obtained using nocodazole treat-
ment. Lysates were immunoprecipitated with an anti-
Mfn1 antibody and ubiquitylation levels were assessed by
immunoblotting. Extensively poly-ubiquitylated Mfn1
was observed in G2/M-phase cells. Notably, the ubiquity-
lation of Mfn1 was reduced in Myc-MARCH5H43W, indi-
cating that MARCH5 regulates the ubiquitylation of
Mfn1 at the G2/M phase (Figure 3C).
In conclusion, we here postulate a new cell cycle-
dependent regulatory mechanism for Mfn1. Mfn1 is ubi-
quitylated by MARCH5 at G2/M phase and degraded in
a proteasome-dependent manner. Furthermore, there is
likely that the MARCH5-mediated Mfn1 degradation in
G2/M phase can be modulated by Cdk1/cyclin B1
kinase.
Materials and methods
Cell culture, cell synchronization, and transfection
HeLa cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM; Invitrogen) supplemented with
10% heat-inactivated fetal bovine serum and 1%
antibiotic-antimycotic at 37°C in a humidified 5% CO2
atmosphere. Plasmid DNA were transfected to the cells
Figure 3 Mfn1 is ubiquitylated by MARCH5 at G2 phase. (A) Cells were transfected with pcDNA or Myc-MARCH5 WT, and exposed to
nocodazole. Myc-MARCH5 WT-expressing cells were incubated with MG132. Lysates were analyzed by immunoblotting with the indicated
antibodies. (B) Cells were co-transfected with HA-ub. GFP-Mfn1 with pcDNA or Myc-MARCH5 WT. G2/M-arrested cells were obtained by treatment
with nocodazole and then treated with MG132. Lysates were immunoprecipitated with an anti-GFP antibody for ubiquitylation assays. GFP-Mfn1
ubiquitylation levels were evaluated with an anti-ub antibody. (C) Cells were co-transfected with HA-ub and pcDNA, Mcy-MARCH5 WT or Myc-
MARCH5H43W, after which cells were synchronized at G2/M by treatment with nocodazole with MG132. The ubiquitylation levels of endogenous
Mfn1 were assayed by immunoblotting.
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described [6]. HeLa cells were synchronized at the G1/S
boundary using the DTB method. Briefly, cells were
incubated with 2 mM thymidine for 20 h, followed by
release in thymidine-free medium for 8 h. The cells were
incubated one more time with 2 mM thymidine for
16 h. G2/M-arrested cells were isolated by treating with
100 ng/ml of nocodazole for 12 h before harvesting.
Plasmid construction
The mammalian MARCH5-YFP expression plasmid has
been described previously [6]. The Myc-MARCH5 ex-
pression plasmid was created by sub-cloning MARCH5-
YFP with 3x-Myc into pcDNA3.1(−)MARCH5 was
digested with XhoI and BamH1, 3x-Myc was digested
with NheI and XhoI, and the two fragments were ligated
into pcDNA 3.1(−) that had been digested with Nhe1
and BamH1.
Immunocytochemistry and confocal microscopy
HeLa cells were seeded on coverslips and synchronized
using the DTB method or by treatment of 100 ng/ml
nocodazole. The synchronized cells were then incubated
with 125 nM MitoTracker Red (Molecular Probes) for
30 min, washed and fixed with 4% paraformaldehyde so-
lution for 10 min, and then washed three times with
phosphate-buffered saline (PBS). Fixed cells werepermeabilized by incubating with methanol for 20 min
at -20°C. For immunofluorescence staining, cells were
blocked with 1% bovine serum albumin in PBS for 1 h at
room temperature, followed by incubation first with pri-
mary antibodies overnight at 4°C and then with
fluorescence-conjugated secondary antibodies. Images
were obtained and analyzed using an LSM510 Confocal
Microscope (Carl Zeiss).
Immunoprecipitation and in vivo ubiquitylation assay
For immunoprecipitation experiments, HeLa cells were
synchronized at G2/M phase with 10 ng/ml of nocoda-
zole, and mitotic floating cells and residual adherent
cells were harvested separately or collectively. Collected
cells were suspended and sonicated in immunoprecipita-
tion (IP) buffer (50 mM HEPES pH 7.5, 150 mM NaCl,
0.1% NP-40, 5 mM EDTA, 1 mM DTT, and protease in-
hibitor). For cyclin B11 immunoprecipitations, whole-
cell lysates containing 500–1500 μg of proteins were
immunoprecipitated with 1 μg of anti-cyclin B11 anti-
body by incubating at 4°C overnight with agitation.
Protein-antibody complexes were further incubated with
25 μlof protein A-sepharose beads (GE Healthcare Bio-
Science AB) for 1 h and 30 min. After washing beads
and protein complexes four times with IP buffer fol-
lowed by heating in 2X sample buffer, samples were sepa-
rated by SDS-PAGE and analyzed by immunoblotting.
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immunoblotting as described for cyclin B11 immunopre-
cipitates. For In Vivo ubiquitinylation assays, HeLa cells
synchronized with 10 ng/ml of nocodazole were treated
20 μM MG132 for 4 h before harvesting.
Immunoblotting and antibodies
Cells were lysed and sonicated in E1A lysis buffer
(50 mM HEPES pH 7.5, 150 mM NaCl, 0.1% NP-40,
5 mM EDTA, 1 mM DTT, and protease inhibitor) fol-
lowed by centrifugation. Supernatants were normalized
for protein content and boiled with Laemmli sample
buffer. The lysates were separated by SDS-PAGE and
analyzed by immunoblotting with anti-Mfn1 (Protein
Tech), anti-Cyclin B11, anti-ubiquitin and anti-c-Myc
(Santa Cruz Biotechnology) antibodies.
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